- Report
- September 2023
- 270 Pages
Global
€4300EUR$4,795USD£3,687GBP
- Report
- August 2025
- 150 Pages
Global
From €2834EUR$3,160USD£2,430GBP
€3542EUR$3,950USD£3,037GBP
- Report
- August 2025
- 150 Pages
Global
From €2834EUR$3,160USD£2,430GBP
€3542EUR$3,950USD£3,037GBP
- Report
- August 2025
- 150 Pages
Global
From €2834EUR$3,160USD£2,430GBP
€3542EUR$3,950USD£3,037GBP
- Report
- August 2025
- 150 Pages
Global
From €2834EUR$3,160USD£2,430GBP
€3542EUR$3,950USD£3,037GBP
- Report
- August 2025
- 150 Pages
Global
From €2834EUR$3,160USD£2,430GBP
€3542EUR$3,950USD£3,037GBP
- Report
- August 2025
- 145 Pages
Global
From €3542EUR$3,950USD£3,037GBP
- Report
- March 2026
- 150 Pages
Canada
From €4349EUR$4,850USD£3,729GBP
- Report
- March 2026
- 150 Pages
China
From €4349EUR$4,850USD£3,729GBP
- Report
- March 2026
- 150 Pages
Germany
From €4349EUR$4,850USD£3,729GBP
- Report
- March 2026
- 150 Pages
India
From €4349EUR$4,850USD£3,729GBP
- Report
- March 2026
- 314 Pages
Canada
From €4349EUR$4,850USD£3,729GBP
- Report
- March 2026
- 150 Pages
Germany
From €4349EUR$4,850USD£3,729GBP
- Report
- March 2026
- 181 Pages
India
From €4349EUR$4,850USD£3,729GBP
- Report
- March 2026
- 353 Pages
China
From €4349EUR$4,850USD£3,729GBP
- Report
- February 2026
- 172 Pages
Canada
From €4349EUR$4,850USD£3,729GBP
- Report
- February 2026
- 226 Pages
China
From €4349EUR$4,850USD£3,729GBP
- Report
- February 2026
- 280 Pages
India
From €4349EUR$4,850USD£3,729GBP
- Report
- July 2025
- 150 Pages
Global
From €4349EUR$4,850USD£3,729GBP
- Report
- July 2025
- 150 Pages
Global
From €4349EUR$4,850USD£3,729GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more